Frankfurt - Delayed Quote EUR
Prothena Corporation plc (0PT.F)
4.2000
+0.0200
+(0.48%)
At close: 9:46:58 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-130,362
-150,050
-133,906
-108,821
92,605
Investing Cash Flow
-237
-298
-2,773
-464
-575
Financing Cash Flow
670
1,554
45,103
241,457
190,332
End Cash Position
418,795
472,248
621,042
712,618
580,446
Income Tax Paid Supplemental Data
3,152
3,172
1,554
2,659
580
Capital Expenditure
-237
-298
-2,810
-464
-575
Issuance of Capital Stock
--
0
23,583
223,616
174,788
Repurchase of Capital Stock
-347
-353
--
--
--
Free Cash Flow
-130,599
-150,348
-136,716
-109,285
92,030
12/31/2021 - 1/11/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IDD.F Innate Pharma S.A.
1.7080
+0.12%
FYB.SG Formycon AG
27.10
-4.07%
IPHYF Innate Pharma S.A.
1.7350
+19.66%
5NRA.MU Nanobiotix SA
4.6400
+5.94%
9VC.F Atai Life Sciences N.V.
1.7920
-1.86%
ALCLS.PA Cellectis S.A.
1.2800
+0.16%
FYB.F Formycon AG
27.20
-3.55%
RGO.SG Regeneron Pharmaceuticals Inc
456.80
+1.53%
GNLX Genelux Corporation
3.0600
+15.47%
LXEO Lexeo Therapeutics, Inc.
3.9400
-3.67%